Why the study?
Does catheter ablation improve outcomes compared to medical therapy in patients with symptomatic atrial fibrillation?
Does catheter ablation improve outcomes compared to medical therapy in patients with symptomatic atrial fibrillation?
Catheter ablation is increasingly recognized as a superior first-line alternative to antiarrhythmic medications for symptomatic atrial fibrillation.
May support first-line ablation consideration in symptomatic AF; leaves open need for updated RCTs in contemporary cohorts.
Atrial fibrillation (AF) is a common clinical problem that is associated with an impaired quality of life, thromboembolism, heart failure and death. Medical treatment of AF remains suboptimal and is associated with potentially serious side effects. The disappointing outcomes with medical therapy have spurred the age of catheter ablation of AF. In the last 10 years, catheter ablation of AF has evolved dramatically and has been shown to be superior to medical therapy in multiple studies. As a result, catheter ablation may be offered to the symptomatic patient as first-line therapy in lieu of antiarrhythmic medications, which have limited efficacy and are associated with significant toxicity.
No takes yet. Share an insight, caveat, or question.
Aman Chugh (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: